BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26281962)

  • 1. Motor neuron disease: Are diabetes and amyotrophic lateral sclerosis related?
    Logroscino G
    Nat Rev Neurol; 2015 Sep; 11(9):488-90. PubMed ID: 26281962
    [No Abstract]   [Full Text] [Related]  

  • 2. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular genetic approach to amyotrophic lateral sclerosis.
    Siddique T; Hu P; Hentati A; Deng G; Hung WY; McInnis MG; Warren AC; Rimmler J; Antonarakis S; Pericak-Vance MA
    Int J Neurol; 1991-1992; 25-26():60-9. PubMed ID: 11980064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
    Pasinelli P; Brown RH
    Nat Rev Neurosci; 2006 Sep; 7(9):710-23. PubMed ID: 16924260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontal lobe dysfunction in ALS].
    Alcaz S; Apostolski S
    Srp Arh Celok Lek; 1995; 123(9-10):266-70. PubMed ID: 17974446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging targets and treatments in amyotrophic lateral sclerosis.
    Zinman L; Cudkowicz M
    Lancet Neurol; 2011 May; 10(5):481-90. PubMed ID: 21511200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monozygotic twins discordant for primary lateral sclerosis.
    Sorenson EJ
    Amyotroph Lateral Scler; 2006 Jun; 7(2):123-5. PubMed ID: 16753978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities.
    Clark R; Blizzard C; Dickson T
    Neurodegener Dis Manag; 2015 Dec; 5(6):511-25. PubMed ID: 26619150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ALS (amyotrophic lateral sclerosis) as a motor neuron disease--physiopathology].
    Yase Y
    Kango Gijutsu; 1983 Mar; 29(4):429-35. PubMed ID: 6551514
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethnic and demographic incidence of amyotrophic lateral sclerosis (ALS) in Brazil: A population based study.
    Moura MC; Casulari LA; Carvalho Garbi Novaes MR
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(3-4):275-81. PubMed ID: 26850047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis: a global threat with a possible difference in risk across ethnicities.
    Logroscino G; Armon C
    Neurology; 2007 Mar; 68(13):E17. PubMed ID: 17389297
    [No Abstract]   [Full Text] [Related]  

  • 12. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis.
    Smith RG; Hamilton S; Hofmann F; Schneider T; Nastainczyk W; Birnbaumer L; Stefani E; Appel SH
    N Engl J Med; 1992 Dec; 327(24):1721-8. PubMed ID: 1331790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons.
    Chou SM; Norris FH
    Muscle Nerve; 1993 Aug; 16(8):864-9. PubMed ID: 8332139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of genetic background on onset and disease progression in the SOD1-G93A model of amyotrophic lateral sclerosis.
    Mancuso R; Oliván S; Mancera P; Pastén-Zamorano A; Manzano R; Casas C; Osta R; Navarro X
    Amyotroph Lateral Scler; 2012 May; 13(3):302-10. PubMed ID: 22424126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous activity in electromyography may differentiate certain benign lower motor neuron disease forms from amyotrophic lateral sclerosis.
    Jokela ME; Jääskeläinen SK; Sandell S; Palmio J; Penttilä S; Saukkonen A; Soikkeli R; Udd B
    J Neurol Sci; 2015 Aug; 355(1-2):143-6. PubMed ID: 26059445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of diabetes in a familial amyotrophic lateral sclerosis patient carrying the I113T SOD1 mutation. Case Report.
    Hamasaki H; Takeuchi Y; Masui Y; Ohta Y; Abe K; Yoshino H; Yanai H
    Neuro Endocrinol Lett; 2015; 36(5):414-6. PubMed ID: 26707039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic research in neuropsychiatry. Demonstrated in Charcot's disease (1865-1965)].
    Haberlandt WF
    Med Welt; 1969 Sep; 39():2118-22. PubMed ID: 4900533
    [No Abstract]   [Full Text] [Related]  

  • 20. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis.
    Körner S; Kollewe K; Fahlbusch M; Zapf A; Dengler R; Krampfl K; Petri S
    Muscle Nerve; 2011 May; 43(5):636-42. PubMed ID: 21484822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.